Mutations in the gene for LRRK2 are the most common cause of familial Parkinson's disease (PD) and patients with these mutations manifest clinical features that are indistinguishable from those of the more common sporadic form. Thus, investigations of disease mechanisms based on disease-causing LRRK2 mutations can be expected to shed light on the more common sporadic form as well as the inherited form. We have shown that as human BAC transgenic hLRRK2(R1441G) mice age, they exhibit two abnormalities in the nigrostriatal dopaminergic system: an axonopathy and a diminished number of dendrites in the substantia nigra (SN). To better understand disease mechanisms it is useful to determine where in the affected neural system the pathology first begins. We therefore examined the nigrostriatal dopaminergic system in young mice to determine the initial site of pathology. Brains from hLRRK2(R1441G) and littermate control mice at 2-4 months of age were examined by immunohistochemistry, anterograde fluorescent axon labeling and ultrastructural analysis. SN neurons, their projecting axons and the striatal terminal fields were assessed. The first identifiable abnormality in this system is an axonopathy characterized by giant polymorphic axon spheroids, the presence of intra-axonal autophagic vacuoles and intra-axonal myelin invagination. An initial involvement of axons has also been reported for other genetic models of PD. These observations support the concept that axons are involved early in the course of the disease. We suggest that effective neuroprotective approaches will be aimed at preventing axonal degeneration.
provided invaluable opportunities to begin to understand the pathogenesis of the disease and the development of novel animal models. One of the common themes to emerge from studies of LRRK2 has been that it may play a role in the development and maintenance of neural processes, both dendrites and axons. MacLeod and colleagues observed in primary cortical cultures that mutant forms of LRRK2 induce neurite retraction, whereas knock down of endogenous LRRK2 by shRNA vectors results in greater neurite length (MacLeod et al., 2006) . Plowey et al. also noted an induction of neurite retraction by the G2019S mutant in SH-SY5Y cells, associated with activation of macroautophagy (Plowey et al., 2008) . Observations supporting a role for LRRK2 in the regulation of neurite growth and maintenance have been made in vivo as well. In Caenorhabditis elegans, the LRRK2 homolog, lrk-1, regulates the trafficking of synaptic vesicle proteins to axon terminals (Sakaguchi-Nakashima et al., 2007) . Loss of the LRRK2 homolog in Drosophila results in synaptic overgrowth at the neuromuscular junction, an effect that is due to phosphorylation of a microtubule-binding protein (Lee et al., 2010) . In transgenic Drosophila expressing the human G2019S mutant, dendrite degeneration occurs as a result of ectopic expression of tau in dendrites. hLRRK2(G2019S) appears to mediate this effect indirectly, by phosphorylation and activation of the homolog of glycogen synthase kinase 3β, which, in turn, phosphorylates tau (Lin et al., 2010) .
